WO2025051401 - A MEDICAMENT DELIVERY DEVICE WITH REDUCED CARBON FOOTPRINT
National phase entry:
Publication Number
WO/2025/051401
Publication Date
13.03.2025
International Application No.
PCT/EP2024/061988
International Filing Date
01.05.2024
Title **
[English]
A MEDICAMENT DELIVERY DEVICE WITH REDUCED CARBON FOOTPRINT
[French]
DISPOSITIF D'ADMINISTRATION DE MÉDICAMENT À EMPREINTE CARBONE RÉDUITE
Applicants **
YPSOMED AG
Inventors
KAUFMANN, Nadine
FONTANELLAZ, Thomas
HEINIGER, Beat
GYGAX, Bernhard
FISCHER, Roger
Priority Data
PCT/EP2023/074235
05.09.2023
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2023 | |
| EPO | Filing, Examination, Granting | 8163 | |
| Japan | Filing, Examination, Granting | 2171 | |
| South Korea | Filing, Examination, Granting | 2057 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
19,154
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
A medicament delivery device including a main housing including a wall defining an inner volume and including a first connector (6) that is part of the wall. A first housing part located within the inner volume and including a second connector (7) and a connection between the first connector and the second connector connecting the first housing part to the main housing. A second housing part (2, 18, 19) is configured for attachment to an outer surface of the main housing thereby at least partially covering and fixating the first connector and the main housing and/or the first housing part is constructed from a bio-based polymer or from a recycled polymer.[French]
L'invention concerne un dispositif d'administration de médicament comprenant un boîtier principal comprenant une paroi définissant un volume interne et comprenant un premier connecteur (6) qui fait partie de la paroi. Une première partie de boîtier située à l'intérieur du volume interne comprend un second connecteur (7) et une connexion entre le premier connecteur et le second connecteur reliant la première partie de boîtier au boîtier principal. Une seconde partie de boîtier (2, 18, 19) est conçue pour être fixée à une surface externe du boîtier principal, recouvrant et fixant ainsi au moins partiellement le premier connecteur et le boîtier principal et/ou la première partie de boîtier étant construite à partir d'un polymère d'origine biologique ou d'un polymère recyclé.